Frontage Welcomes Glenn Washer, BSc, DABT as Executive Vice President, Global Safety & Toxicology Services

EXTON, Pa., March 10, 2020 /PRNewswire/ — Frontage Laboratories is pleased to announce that Glenn Washer, BSc, DABT has joined Frontage as our Executive Vice President, Global Safety & Toxicology Services.  Glenn will report directly to Dr. Song Li, CEO.

Glenn has more than 35 years of experience in increasingly responsible roles within the realm of Safety/Toxicology at various companies.  In his most recent position, Glenn served as the President, Charles River Laboratories, Montreal, Canada and as the Corporate Senior Vice President, for Charles River’s North America Safety Assessment sites.  He brings a wealth of knowledge and experience to his new role, including extensive executive management experience and P&L responsibility in regulated contract research and biopharmaceuticals industries with emphasis on multi-site, multi-national CRO management, research & development.  Glenn has in-depth knowledge and experience in operations management, M&A due diligence, integration of new acquisitions, organizational restructuring, and strategic planning.

Glenn will be responsible for the overall leadership and the strategic global growth of the Safety/Toxicology business at Frontage Laboratories. 

“We’re very excited to welcome Mr. Glenn Washer onboard as our Executive Vice President, Global Safety and Toxicology”, said Dr. Song Li, CEO of Frontage Laboratories, “Mr. Washer’s experience in preclinical drug development, safety and toxicology, translational science and medicine makes him ideally suited to taking this role. We have confidence in his leadership to strengthen Frontage’s capabilities and capacities in preclinical development globally”.

Mr. Washer commented: “I am very excited to be joining the impressive team at Frontage.  Their leadership team’s dedication to the highest levels of scientific rigor, quality, customer service, and employee development give me great confidence that we share the same values and vision.  I look forward to the opportunity to contribute to the continued growth of this exceptional global organization.”

For more information: https://www.frontagelab.com/about/news-item/frontage-welcomes-glenn-washer/

Contact: Shannon C. Ryan
Sryan@frontagelab.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/frontage-welcomes-glenn-washer-bsc-dabt-as-executive-vice-president-global-safety–toxicology-services-301020707.html

SOURCE Frontage Laboratories, Inc.

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

17 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

17 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

17 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

17 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

17 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

17 hours ago